In addition, activated TGF-β signaling leads to induction of epithelial-to-mesenchymal transition, which is known to be implicated in tumor progression, metastatic spread and increased chemoresistance [16, 17, 10]. The gene discussed is TGFB1; the disease is neoplasm.